27514764|t|Renoprotective Effect of Plantago Major Against Nephrotoxicity and Oxidative Stress Induced by Cisplatin
27514764|a|The aim of this study was to investigate the possible renoprotective effect of Plantago major extract against cisplatin -induced nephrotoxicity in rats. Rats were divided into 6 groups. The first group was the control, group 2 was treated with cisplatin (7 mg/kg, single dose), and groups 3 to 6 received cisplatin with vitamin E (100 mg/kg) and Plantago major extract at doses of 300 mg/kg, 600 mg/kg, and 1200 mg/kg, for 20 days. On day12, serum concentration of urea, creatinine, and potassium significantly increased and sodium concentration significantly decreased in the cisplatin group compared with the control rats. However, serum creatinine, urea, and potassium concentrations were significantly lower in all of the Plantago major groups compared to the cisplatin group. Also, there was a significant elevation in serum sodium concentration in the Plantago major 600 mg/kg group compared to the cisplatin group on day12. Injection of cisplatin caused a significant elevation in malondialdehyde concentration but a significant decrease in catalase activity and total thiol content compared to the control group. Plantago major extract at 1200 mg/kg significantly improved malondialdehyde concentration and total thiol content compared to the cisplatin group. Catalase activity with Plantago major significantly increased at all doses compared to the cisplatin group. The current study suggests that Plantago major extract and vitamin E are able to improve kidney function as well as oxidative stress in cisplatin -induced renal toxicity in the rat.
27514764	0	21	Renoprotective Effect	T201	C1527144
27514764	25	39	Plantago Major	T109,T121	C3488573
27514764	48	62	Nephrotoxicity	T037	C0599918
27514764	67	83	Oxidative Stress	T049	C0242606
27514764	95	104	Cisplatin	T121,T197	C0008838
27514764	159	180	renoprotective effect	T201	C1527144
27514764	184	206	Plantago major extract	T109,T121	C3488573
27514764	215	224	cisplatin	T121,T197	C0008838
27514764	234	248	nephrotoxicity	T037	C0599918
27514764	252	256	rats	T015	C0034721
27514764	258	262	Rats	T015	C0034721
27514764	301	306	group	T078	C0441833
27514764	315	322	control	T096	C0009932
27514764	324	331	group 2	T078	C0441833
27514764	336	348	treated with	T061	C0332293
27514764	349	358	cisplatin	T121,T197	C0008838
27514764	369	375	single	T081	C0205171
27514764	376	380	dose	T081	C0870450
27514764	387	395	groups 3	T078	C0441833
27514764	401	409	received	T061	C0332293
27514764	410	419	cisplatin	T121,T197	C0008838
27514764	425	434	vitamin E	T109,T121,T127	C0042874
27514764	451	473	Plantago major extract	T109,T121	C3488573
27514764	477	482	doses	T081	C0870450
27514764	547	566	serum concentration	T081	C0683149
27514764	570	574	urea	T033	C0857448
27514764	576	586	creatinine	T033	C0700225
27514764	592	625	potassium significantly increased	T033	C0553704
27514764	630	674	sodium concentration significantly decreased	T033	C1559979
27514764	682	691	cisplatin	T121,T197	C0008838
27514764	692	697	group	T078	C0441833
27514764	716	723	control	T096	C0009932
27514764	724	728	rats	T015	C0034721
27514764	739	755	serum creatinine	T033	C0428282
27514764	757	761	urea	T033	C0236032
27514764	767	816	potassium concentrations were significantly lower	T033	C0595885
27514764	831	845	Plantago major	T109,T121	C3488573
27514764	846	852	groups	T078	C0441833
27514764	869	878	cisplatin	T121,T197	C0008838
27514764	879	884	group	T078	C0441833
27514764	916	955	elevation in serum sodium concentration	T033	C1559973
27514764	963	977	Plantago major	T109,T121	C3488573
27514764	988	993	group	T078	C0441833
27514764	1010	1019	cisplatin	T121,T197	C0008838
27514764	1020	1025	group	T078	C0441833
27514764	1036	1045	Injection	T061	C0021485
27514764	1049	1058	cisplatin	T121,T197	C0008838
27514764	1080	1089	elevation	T082	C0702240
27514764	1093	1122	malondialdehyde concentration	T059	C2322214
27514764	1141	1170	decrease in catalase activity	T033	C4022869
27514764	1175	1194	total thiol content	T059	C2367104
27514764	1211	1224	control group	T096	C0009932
27514764	1226	1248	Plantago major extract	T109,T121	C3488573
27514764	1277	1285	improved	T033	C0184511
27514764	1286	1315	malondialdehyde concentration	T059	C2322214
27514764	1320	1339	total thiol content	T059	C2367104
27514764	1356	1365	cisplatin	T121,T197	C0008838
27514764	1366	1371	group	T078	C0441833
27514764	1373	1390	Catalase activity	T044	C1151515
27514764	1396	1410	Plantago major	T109,T121	C3488573
27514764	1425	1434	increased	T081	C0205217
27514764	1442	1447	doses	T081	C0870450
27514764	1464	1473	cisplatin	T121,T197	C0008838
27514764	1474	1479	group	T078	C0441833
27514764	1513	1535	Plantago major extract	T109,T121	C3488573
27514764	1540	1549	vitamin E	T109,T121,T127	C0042874
27514764	1570	1585	kidney function	T042	C0232804
27514764	1597	1613	oxidative stress	T049	C0242606
27514764	1617	1626	cisplatin	T121,T197	C0008838
27514764	1636	1650	renal toxicity	T037	C0599918
27514764	1658	1661	rat	T015	C0034721